What are the Therapeutic Implications of Targeting IL-17?
Given its role in inflammation and autoimmune diseases, IL-17 has become a target for therapeutic intervention. Monoclonal antibodies that inhibit IL-17 or its receptor have been developed and are used in the treatment of conditions like psoriasis and ankylosing spondylitis. These therapies have shown significant efficacy in reducing inflammation and improving clinical outcomes.
